Coloplast Comfort Medical Doesn't Make a Dental Chair or a Pacemaker. That's Why Procurement Trusts It

I do not trust a medical supplier that says it can do everything. “We do everything” is not a promise; it’s a red flag. I know that sounds backwards—most buying teams want fewer vendors, not more. But after seven years of purchasing medical supplies and equipment, I’ve never seen a generalist do a brilliant job in a clinical category that sits far outside its core expertise.

Let me give you the context. I’m the procurement manager for a regional post-acute care network: five skilled nursing facilities, a home health agency, and an outpatient wound clinic. I manage a supply and equipment budget of roughly $460,000 a year. I judge purchases on total cost of ownership, not on unit price. Unit price is where the nice conversations happen. Total cost is where overpromising suppliers start to hurt.

A patient transfer device taught me what “yes” really means

The lesson landed in my first year on the job, delivered through a classic rookie mistake. One of our facility directors needed patient transfer devices for a new bariatric wing. Instead of calling a mobility-equipment specialist, I asked the full-line distributor that already handled our commodity supplies for a quote. Their sales rep said yes within an hour: “We can cover that for you. Free setup, no problem.”

He wasn’t lying—he also wasn’t asking the right questions. The free setup didn’t include a site survey, a corridor clearance check, or staff training. When the equipment arrived, it wouldn’t fit through the doorway it was meant for. By the time we paid the return fee, the restocking charge, and the expedited replacement, that convenient “yes” cost us about $1,100 in fees and three weeks of nursing time.

We ended up buying from a vendor that does one thing: patient transfer and mobility equipment. Its quote looked roughly $700 higher on the first page. Then the line items appeared—site visit, sling sizing, training, maintenance schedule. Over two years, that purchase cost us around $3,400 less than the distributor’s option would have. The difference was hidden in details I hadn’t verified.

When I audited our 2023 purchasing, I found that roughly 6 percent of the budget had gone to reorders, corrections, and fees generated by suppliers saying yes outside their lane. Don’t quote me on the exact number—I’d have to pull the spreadsheet again—but the direction was unmistakable. Once we required a documented reason for every multi-category award, that waste dropped below 2 percent. It’s real money, about $14,000 in the first year.

“That isn’t our lane” is a sign of credibility

So now I listen for the sentence that makes sales reps uncomfortable. It isn’t the price. It’s this: “That isn’t what we do.” It sounds like a lost order. In practice, it is the most credible thing a supplier can say to me, because it tells me they know their lane—and that they will stay answerable for the things they claim.

Coloplast is a useful example. The company’s name appears across our chronic-care orders, and the Coloplast Comfort Medical brand shows up on invoices for catheters, ostomy supplies, wound dressings, and skin care products. What makes the brand easy to buy from is that it is easy to categorize. Its range and its clinical education stay in one coherent lane: chronic care. Coloplast doesn’t try to be a full-line department store, and it doesn’t blur its message to chase a broader catalog. That clarity cuts my research time and reduces my risk. I’ll take it over a vague “we can get you anything” pitch any week.

There is also a compliance side. Under FTC advertising guidance (ftc.gov), objective product claims have to be truthful and substantiated. In medical procurement, an unsubstantiated capability claim is not just a marketing problem. It can ripple into patient safety, regulatory audits, and tender disqualification. When a supplier carefully limits what it claims, I can quickly verify that its products and education align with its stated scope. When it claims everything, I have to verify everything. That costs staff time, and I resent paying for it.

What a pacemaker question taught me about positioning

The point became practical last quarter, when a new clinical coordinator asked me a genuine question: “What is a pacemaker, anyway? Could we add that category to our supply contract so we don’t need another vendor?” It’s an easy question to laugh at, but it makes sense if you haven’t worked in cardiology.

In plain language, a pacemaker is a small, battery-powered implant placed under the skin near the collarbone. It monitors the heart and delivers a tiny electrical pulse when the rhythm becomes too slow or pauses. It is an implantable cardiac device, with a completely different regulatory path, supply chain, training model, and service requirement than a wound dressing or an intermittent catheter. No credible chronic-care company should pretend an implantable cardiac device is an add-on to an ostomy order. Asking them to do so is asking them to fail.

The same logic explains why someone might type “Coloplast dental chair” into a search engine. When you trust a healthcare brand in one category, it is tempting to assume that trust transfers to every other category. It doesn’t. A dental chair belongs to dental-equipment specialists. A patient transfer device belongs to mobility specialists. A pacemaker belongs to cardiac-device specialists. Chronic-care products belong to companies like Coloplast. Each lane has its own evidence, service model, and risk—and choosing the right lane is the real procurement skill.

But isn’t fewer vendors cheaper?

I can hear the objection coming: consolidation reduces paperwork and earns volume discounts. I agree, up to a point. We use broad distributors for commodity items, and the strategy works. But there is a difference between a distributor and a clinical specialist. A distributor is a logistics operation that aggregates catalogs and negotiates price. A specialist is accountable for outcomes. When a company claims expertise across unrelated clinical categories, it is asking me to trust its brand in every room. I don’t. I’ve been burned by that trust, and I have the reorder history to prove it.

I’m not saying every supplier should stay microscopic. If a company can demonstrate genuine competence in an adjacent category—staff, data, regulatory clearance, clinical support—I will happily expand its share of my budget. But the burden of proof sits with the vendor. “We can do that too” is not evidence.

A caveat from my own spreadsheets

My experience has limits, and I should name them. I’ve worked in post-acute and home health procurement for seven years. We do not buy imaging equipment, dental chairs, or implantable cardiac devices, and our volumes are modest compared with a large acute-care hospital. If you run a cardiac service line or a dental group, your supplier map may look different—you might genuinely benefit from integrated contracts that a small buyer like us doesn’t need. That’s fine. The principle I hold onto is not “never consolidate.” It is: make sure the person claiming expertise actually has it.

I’d rather work with a specialist that knows its limits than a generalist that overpromises—especially when the product ends up on a human being.

That’s the standard that guides my budget. Coloplast Comfort Medical earns our chronic-care business because it is easy to understand: a specialty in chronic care, backed by product range, clinical education, and data. It doesn’t need to be a pacemaker company or a dental chair company to get my purchase orders. Staying in its lane is exactly what makes its lane worth buying from.